Výsledky vyhledávání - Geoffrey I. Shapiro
- Zobrazuji výsledky 1 - 20 z 174
- Přejít na další stránku
-
1
Heat Shock Protein 90 Inhibition in Lung Cancer Autor Takeshi Shimamura, Geoffrey I. Shapiro
Vydáno 2008Revisão -
2
-
3
-
4
Anticancer drug targets: cell cycle and checkpoint control Autor Geoffrey I. Shapiro, J. Wade Harper
Vydáno 1999Revisão -
5
-
6
-
7
Targeting CDK4 and CDK6: From Discovery to Therapy Autor Charles J. Sherr, David Beach, Geoffrey I. Shapiro
Vydáno 2015Revisão -
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
The Aurora Kinase Inhibitor VX-680 Induces Endoreduplication and Apoptosis Preferentially in Cells with Compromised p53-Dependent Postmitotic Checkpoint Function Autor Farid Gizatullin, Yao Yao, Victor Kung, Matthew W. Harding, Massimo Loda, Geoffrey I. Shapiro
Vydáno 2006Artigo -
17
Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST Autor Mizuki Nishino, Jyothi P. Jagannathan, Katherine M. Krajewski, Kevin OʼRegan, Hiroto Hatabu, Geoffrey I. Shapiro, Nikhil H. Ramaiya
Vydáno 2012Revisão -
18
First-in-Human Phase I Dose Escalation Study of a Second-Generation Non-Ansamycin HSP90 Inhibitor, AT13387, in Patients with Advanced Solid Tumors Autor Geoffrey I. Shapiro, Eunice L. Kwak, Bruce J. Dezube, Murray Yule, John Ayrton, John F. Lyons, Daruka Mahadevan
Vydáno 2014Artigo -
19
-
20
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Cancer
Biology
Cancer research
Oncology
Genetics
Gene
Biochemistry
Pharmacology
Adverse effect
Lung cancer
Gastroenterology
Pharmacokinetics
Breast cancer
Cell biology
Chemotherapy
Kinase
Pathology
Cell cycle
Pharmacodynamics
Poly ADP ribose polymerase
Polymerase
Tolerability
Chemistry
DNA
PARP inhibitor
Receptor
Signal transduction
Clinical trial